PRICES include / exclude VAT
Homepage>BS Standards>11 HEALTH CARE TECHNOLOGY>11.040 Medical equipment>11.040.01 Medical equipment in general>PD CEN ISO/TR 20416:2020 Medical devices. Post-market surveillance for manufacturers
Sponsored link
immediate downloadReleased: 2020-08-19
PD CEN ISO/TR 20416:2020 Medical devices. Post-market surveillance for manufacturers

PD CEN ISO/TR 20416:2020

Medical devices. Post-market surveillance for manufacturers

Format
Availability
Price and currency
English Secure PDF
Immediate download
370.26 EUR
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
37.03 EUR
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
111.08 EUR
English Hardcopy
In stock
370.26 EUR
Standard number:PD CEN ISO/TR 20416:2020
Pages:52
Released:2020-08-19
ISBN:978 0 580 97101 3
Status:Standard
PD CEN ISO/TR 20416:2020 - Medical Devices Post-Market Surveillance

PD CEN ISO/TR 20416:2020 - Medical Devices: Post-Market Surveillance for Manufacturers

In the ever-evolving world of medical technology, ensuring the safety and efficacy of medical devices is paramount. The PD CEN ISO/TR 20416:2020 standard is an essential resource for manufacturers who are committed to maintaining the highest standards of quality and safety in their products. Released on August 19, 2020, this comprehensive document provides a detailed framework for post-market surveillance, a critical component in the lifecycle of medical devices.

Why Post-Market Surveillance is Crucial

Post-market surveillance (PMS) is a proactive process that allows manufacturers to monitor the performance of their medical devices once they are available on the market. This ongoing process is vital for identifying potential issues that may not have been apparent during the pre-market phase. By implementing effective PMS, manufacturers can ensure that their devices continue to meet safety and performance standards, thereby protecting patients and maintaining regulatory compliance.

Key Features of PD CEN ISO/TR 20416:2020

  • Comprehensive Guidance: This standard provides detailed guidance on how to establish and maintain a robust post-market surveillance system. It covers all aspects of PMS, from data collection and analysis to reporting and corrective actions.
  • Internationally Recognized: As a CEN ISO/TR standard, it is recognized globally, making it an invaluable resource for manufacturers operating in multiple countries.
  • 52 Pages of In-Depth Information: With 52 pages of detailed content, this standard offers extensive insights and practical advice for implementing effective PMS strategies.
  • ISBN: 978 0 580 97101 3: Easily reference this standard in your documentation and ensure you are using the correct version.

Benefits of Implementing PD CEN ISO/TR 20416:2020

By adhering to the guidelines set forth in this standard, manufacturers can reap numerous benefits, including:

  • Enhanced Product Safety: Continuous monitoring helps identify and mitigate risks, ensuring that devices remain safe for use.
  • Regulatory Compliance: Stay ahead of regulatory requirements by implementing a PMS system that meets international standards.
  • Improved Customer Satisfaction: By addressing potential issues promptly, manufacturers can maintain trust and satisfaction among healthcare providers and patients.
  • Data-Driven Decision Making: Collecting and analyzing post-market data allows manufacturers to make informed decisions about product improvements and innovations.

Who Should Use This Standard?

This standard is designed for manufacturers of medical devices who are committed to maintaining the highest levels of quality and safety. It is particularly beneficial for:

  • Quality Assurance and Regulatory Affairs Professionals
  • Product Development Teams
  • Compliance Officers
  • Risk Management Specialists

Conclusion

The PD CEN ISO/TR 20416:2020 standard is an indispensable tool for any medical device manufacturer looking to implement a robust post-market surveillance system. By following the guidelines outlined in this document, manufacturers can ensure that their products remain safe, effective, and compliant with international standards. This not only protects patients but also enhances the reputation and reliability of the manufacturer in the competitive medical device industry.

Invest in the future of your medical devices by integrating the principles of PD CEN ISO/TR 20416:2020 into your post-market surveillance strategy. With its comprehensive guidance and international recognition, this standard is your key to achieving excellence in medical device safety and performance.

DESCRIPTION

PD CEN ISO/TR 20416:2020


This standard PD CEN ISO/TR 20416:2020 Medical devices. Post-market surveillance for manufacturers is classified in these ICS categories:
  • 11.040.01 Medical equipment in general

This document provides guidance on the post-market surveillance process and is intended for use by medical device manufacturers. This post-market surveillance process is consistent with relevant international standards, in particular ISO 13485 and ISO 14971. This document describes a proactive and systematic process that manufacturers can use to collect and analyse appropriate data, to provide information for the feedback processes and use this to meet applicable regulatory requirements to gain experience from the post-production activities. The output of this process can be used:

  1. as input into product realization;

  2. as input into risk management;

  3. for monitoring and maintaining product requirements;

  4. for communicating to regulatory authorities; or

  5. as input into improvement processes.

This document does not address market surveillance activities to be performed by regulatory authorities. Neither does it specify a manufacturer’s actions required by the applicable regulatory requirements resulting from their production or post-production activities, nor reporting to regulatory authorities. This document is not intended to replace or change applicable regulatory requirements for post-market surveillance.